Lei Zhang | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Prof. Lei Zhang | Clinical Neuroscience | Research Excellence Award

Prof. Lei Zhang | The First Affiliated Hospital of Wenzhou Medical University | China

Lei Zhang is a male Chinese orthopaedic surgeon and scientist, currently serving as Professor, Chief Director, and Master Supervisor in the Department of Orthopaedics at The First Affiliated Hospital of Wenzhou Medical University. He holds both M.D. and Ph.D. degrees from the School of Medicine, Zhejiang University, and specializes clinically in arthroplasty and sports medicine, with a scientific focus on tissue engineering for bone and cartilage repair. His international training includes fellowships at Graz University, Singapore General Hospital, WaldKrankenhaus Hospital in Bonn, Peking University Third Hospital, JST Hospital, and Ewha Womans University Seoul Hospital, reflecting broad exposure to advanced orthopaedic techniques and translational research. Professor Zhang is actively engaged in professional service, holding leadership and membership roles in multiple branches of the Zhejiang Medical Association and related orthopedic, sports medicine, and tissue repair societies. He also contributes to academic publishing as Chief Editor of special issues in Frontiers in Bioengineering and Biotechnology and as Associate Editor for the Injury Prevention and Rehabilitation specialty in Frontiers in Sports and Active Living. His scholarly output includes 89 published documents, with 4,362 total citations from 4,083 citing documents and an h-index of 28, demonstrating sustained impact in orthopaedics, sports medicine, and regenerative tissue engineering.

Citation Metrics (Scopus)

8000
6000
4000
2000
0

Citations
4362

Documents
89

h-index
28

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile
 View Orcid Profile

Featured Publications

Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Dr. Seyed MohamadMehdi Moshtaghion | Cabimer | Spain

Seyed MohamadMehdi Moshtaghion, MD, MSc, is a physician-scientist and Senior Research Technologist specializing in advanced therapies and diagnostic biomarkers for retinal degenerative diseases, with a primary focus on retinitis pigmentosa and age-related macular degeneration. His research integrates molecular biology, stem cell–based strategies, gene therapy, and artificial intelligence–driven retinal imaging to advance early diagnosis and personalized treatment approaches for vision-threatening disorders. He holds a medical degree from Shahid Beheshti University and advanced postgraduate training in biomedical investigation and molecular biology and biomedicine from the University of Seville, along with certification in animal experimentation. Dr. Moshtaghion has conducted research at leading international institutions, including Massachusetts Eye and Ear at Harvard Medical School, Karolinska Institutet, and CABIMER, contributing to translational projects that bridge laboratory discoveries with clinical ophthalmology. He has authored over 20 peer-reviewed scientific publications, with a total of 183 citations, an h-index of 8, and an i10-index of 8, reflecting consistent scholarly impact in the fields of retinal biology and regenerative medicine. His work has been presented at major international conferences such as ARVO and EURETINA, highlighting innovative therapeutic strategies and biomarker discovery in retinal disease research.

Citation Metrics (Google Scholar)

400
300
200
100
0

Citations
183

Documents
20

h-index
8

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Interpretable deep learning for diagnosis of fungal and acanthamoeba keratitis using in vivo confocal microscopy images
– M Essalat, M Abolhosseini, TH Le, SM Moshtaghion, MR Kanavi, Scientific Reports, 13(1): 8953, 2023

Penetrating keratoplasty versus deep anterior lamellar keratoplasty in children and adolescents with keratoconus
– S Feizi, MA Javadi, F Karimian, M Abolhosseini, SM Moshtaghion, American Journal of Ophthalmology, 226: 13–21, 2021

Impression cytology for detection of clinically suspected ocular surface disorders: a cross-sectional study
– SM Moshtaghion, M Abolhosseini, MR Kanavi, SB Hosseini, European Journal of Ophthalmology, 31(3): 943–950, 2021

Outcomes of big-bubble deep anterior lamellar keratoplasty for pediatric keratoconus
– S Feizi, MA Javadi, M Najafi, M Abolhosseini, SM Moshtaghion, International Ophthalmology, 40(5): 1253–1259, 2020

Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Fiona Stanley | Australia

Dr. Hendry Ramly is a clinician–researcher with advanced training in general medicine, cardiology, and intensive care medicine, and a focused academic interest in non-traumatic out-of-hospital cardiac arrest and post-resuscitation care. His research is directly informed by frontline clinical practice across acute medicine, ICU, and cardiology, where he manages critically ill patients following cardiac arrest. Dr. Ramly’s primary research examines cardiovascular management strategies after return of spontaneous circulation, with particular emphasis on haemodynamic stabilisation, coronary pathology, and the timing and utility of urgent coronary angiography. Neurological outcomes are included as standard clinical endpoints, while the central focus remains on cardiovascular determinants of survival and in-hospital mortality. He is lead author of a retrospective observational cohort study published in Heart, Lung and Circulation (2025), evaluating outcomes of non-traumatic out-of-hospital cardiac arrest at a tertiary centre. His additional audit work includes thoracic surgical outcomes, geriatric referral pathways, and procedural adequacy in respiratory medicine. Through clinically driven research and multidisciplinary collaboration, Dr. Ramly aims to refine evidence-based pathways that improve survival, decision-making, and quality of care for patients following cardiac arrest.


View ORCID Profile

Featured Publication

Yuxin Yin | Neurogenetics | Research Excellence Award

Published on by Neuroscientists

Prof. Dr. Yuxin Yin | Neurogenetics | Research Excellence Award

Prof. Dr. Yuxin Yin | The Chinese University of Hong Kong | China

Yuxin Yin is a Presidential Chair Professor at the School of Medicine, The Chinese University of Hong Kong, Shenzhen, recognized for pioneering contributions to molecular oncology, genome stability, and translational systems biomedicine. Trained at UNC-Chapel Hill and Princeton and previously a tenured professor at Columbia University, he later led basic medical sciences at Peking University before joining CUHK-Shenzhen. His research dissects tumor-suppressor signaling networks, including p53 and PTEN pathways, DNA-replication stress responses, genome-stability mechanisms, and the immunological dynamics that shape cancer progression. He has also advanced AI-driven metabolomics for early cancer screening, contributing to cross-disciplinary integration between cancer biology, data science, and neuroscience-inspired approaches. With more than 189 publications and an extensive research portfolio of approximately 190 completed and ongoing projects, his work has been cited over 7,264 times, with 6,352 citing articles and an average of 38.43 citations per item. He holds an H-index of 45, reflecting sustained global influence in cancer biology and biomedical innovation. Beyond academia, Yin contributes to translational and industry-facing initiatives, including AI-metabolomics screening programs and multidisciplinary collaborations that accelerate precision medicine. His leadership and scientific achievements continue to shape emerging directions in cancer research, systems biomedicine, and next-generation diagnostic technologies.

Profile: Orcid

Featured Publications

Lu, Y., Ding, D., Chen, H., Jiang, P., Luo, J., Shan, H., Wang, G., Luo, J., and Yin, Y. (2025). Structural determination of the human taurine transporter TauT reveals the mechanism of substrate and inhibitor recognition. Cell Reports, 116591.

Shen, Z., Zhong, A., Zhang, C., Tang, X., Zhao, X., Hou, Z., Liang, H., and Yin, Y. (2025). LncPTEN1, a long non-coding RNA generated from PTEN, suppresses lung cancer metastasis through the regulation of EMT progress. Non-coding RNA Research.

Tang, X., Zhang, Q., Shen, Z., Xiao, J., Li, M., Meng, X., Wang, C., Zhang, G., Liu, A., and Yin, Y. (2025). Single-cell multi-omics analysis reveals cancer regulatory elements of transcriptional programs and clinical implications. Cell Death & Disease.

Liu, A., Xiao, J., Wang, C., Meng, X., He, C., Li, M., Zhang, G., Tang, X., and Yin, Y. (2025). Single-cell multi-omics analysis reveals the plasticity of isthmus stem cells in gastric carcinogenesis. Computers in Biology and Medicine, 110662.

Li, Y., Zhou, J., Zhang, Z., Jiang, S., Yin, Q., Xiao, J., Li, X., Yin, Y., Ye, L., Peng, S., et al. (2025). RPA1 protects DNA damage induced PANoptosis in limb development. Science Advances.

Yu, S., Ding, J., Wang, J., Wang, W., Zuo, P., Yang, A., Dai, Z., Yin, Y., Sun, J., and Liang, L. (2025). Structural insights into cholesterol sensing by the LYCHOS-mTORC1 pathway. Nature Communications.

Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Chongqing Medical University | China

Professor Hui Gan is a distinguished researcher at Chongqing Medical University, serving as a master’s supervisor, associate research fellow, and Assistant to the Dean of the School of Basic Medical Sciences, where she also leads the Department of Pathophysiology in an acting capacity. Her research primarily focuses on neuroinflammation, microglial regulation, and inflammasome-mediated injury following cerebral hemorrhage, with significant contributions to understanding TRIM21-mediated mechanisms and microglial transcriptional pathways such as c-MAF–NLRP3 signaling. She has secured multiple competitive national and regional research grants supporting investigations into inflammasome activation, microcirculatory dysfunction, and post-hemorrhagic inflammatory injury. Professor Gan has received notable recognitions, including awards for early-career excellence and contributions to microcirculation research. She plays an active role in professional societies as a committee member of the Microcirculation Committee of the Chinese Society of Pathophysiology and a young committee member of the Translational Medicine Committee of the Chinese Society of Microcirculation, contributing to academic development in basic and translational medical sciences. Her scholarly output includes 18 documents, with 196 citations across 175 citing documents, reflecting a solid research impact supported by an h-index of 8. Through her scientific leadership and innovative research, she continues to advance understanding of inflammatory mechanisms in neurological injury.

Profile: Scopus

Featured Publication

Gan, H., Gan, H.-Y., Zhang, M., Duan, Y., Palahati, A., He, Q., Tan, J., Li, Y., Zhai, X., & Zhao, J. (2025). Microglial NFAT5 aggravates neuroinflammation via mediating NLRP6 inflammasome in experimental ischemic stroke. Genes and Diseases, 12(6),

Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Zhi Li | Molecular and Cellular Neuroscience | Best Researcher Award

Assist. Prof. Dr. Zhi Li | Qinghai University | China

Zhi Li is a researcher specializing in cellular biology, infection and immunity, host–pathogen interactions, vector and vector-borne diseases, and zoonoses. His work focuses on understanding the molecular mechanisms underlying host responses to parasitic infections and the epidemiology of emerging infectious diseases in animals. As an Assistant Professor at Qinghai University, he has contributed significantly to research on parasitic pathogens affecting livestock and wildlife in the Qinghai-Tibetan Plateau region. His studies have explored infections caused by Echinococcus shiquicus, Theileria annulata, and various fluke species, emphasizing their identification, transmission dynamics, and host interactions. Through collaborations with national and international researchers, he has published in leading journals such as Transboundary and Emerging Diseases, Parasitology Research, Parasites & Vectors, and Acta Tropica. His research integrates molecular biology, immunological assays, and field epidemiology to develop improved diagnostic tools and better understand pathogen adaptation in diverse ecological settings. By linking laboratory findings with field observations, Zhi Li’s work contributes to controlling zoonotic and vector-borne diseases that threaten both animal and human health, aligning with the global “One Health” approach that connects veterinary and biomedical research for sustainable disease management.

Profile: Orcid

Li, Z., Han, Y., Liu, J.-L., Zhang, X.-Y., Shen, X., Guo, Z.-H., Yin, H., Duo, H., & Fu, Y. (2025). High diversity of Piroplasm species carried by ticks from Qinghai, China. Acta Tropica, 250, 107907.

Fu, Y., Zhang, X., Li, Z., Shi, Z., Ma, X., Meng, R., Zhang, Q., Zhao, C., Guo, S., Ma, W., et al. (2023, November 23). Emerging Echinococcus shiquicus infection of Asian badgers in the Qinghai–Tibetan Plateau. Transboundary and Emerging Diseases, 2023, 6874033.

Fu, Y., Zhang, X., Li, Z., Meng, R., Duo, H., Shen, X., Ma, Y., & Guo, Z. (2023, July). Identification and prevalence of fluke infection in yak and Tibetan sheep around Qinghai Lake, China. Parasitology Research.

Zhang, X., Jian, Y., Li, Z., Duo, H., Guo, Z., & Fu, Y. (2023, February 25). Optimization of single-tube nested PCR for the detection of Echinococcus spp. Experimental Parasitology, 246, 108358.

Liu, J., Zhao, S., Li, Z., Zhang, Z., Zhao, B., Guan, G., Yin, H., & Luo, J. (2023, February 23). Activation of telomerase activity and telomere elongation of host cells by Theileria annulata infection. Frontiers in Microbiology, 14, 1123456.

Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Carmen Berenguer | Behavioral Neuroscience | Women Researcher Award

Assoc. Prof. Dr. Carmen Berenguer | Universitat de Valencia | Spain

Dr. Carmen Berenguer is an Associate Professor in the Department of Developmental and Educational Psychology at the University of Valencia. She holds a degree in Psychology, a Master’s in Cognitive Neuroscience and Special Educational Needs, and a Ph.D. in Psychology with the distinction of Cum Laude and International Doctorate from the same university. Her research has consistently focused on neurodevelopmental disorders, particularly Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD), exploring cognitive, social, communication, and learning dimensions. In recent years, she has extended her work to examine comorbid conditions such as sleep difficulties and to design psychosocial intervention programs for families of children with ASD and ADHD. Dr. Berenguer has completed or participated in nine research projects and authored 20 books. She holds two patents related to psychosocial programs and augmented reality applications for educational and therapeutic purposes. With 54 published documents, her work has been cited in 994 scientific papers, accumulating a total of 1,077 citations and achieving an h-index of 17, reflecting her significant impact in developmental psychology and neurodevelopmental research.

Profiles: Scopus | orcid | Google Scholar

Featured Publications

(2025). Characteristics, motivations and attitudes of students using ChatGPT and other language model-based chatbots in higher education. Education and Information Technologies.

(2025). Parenting stress in autistic and ADHD children: Implications of social support and child characteristics. Journal of Autism and Developmental Disorders.

(2025). Sleep disturbances in autistic children and adolescents: A systematic review and meta-analysis of randomized controlled trials.

(2025). Augmented reality and learning-cognitive outcomes in autism spectrum disorder: A systematic review.

(2025). Occupational stress, burnout, and job satisfaction amongst Spanish speech-language pathologists. International Journal of Speech Language Pathology.

Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Danai Veltra | Neurogenetics and Molecular Neuroscience | Best Researcher Award 

Dr. Danai Veltra | National and Kapodistrian University | Greece

Dr. Danai Veltra is a Greek medical researcher specializing in clinical genetics and genomic medicine, with a strong focus on rare genetic disorders, epileptic encephalopathies, and neurodevelopmental syndromes. Her research contributions encompass genetic diagnostics through Next Generation Sequencing (NGS) and Whole Exome Sequencing (WES), significantly improving the identification and understanding of Mendelian and chromosomal disorders. She has presented her work at numerous prestigious international conferences, including the European Human Genetics Conference and the European Paediatric Neurology Society Congress, where she has contributed to studies on Marfan syndrome, Williams syndrome, Melnick-Needles syndrome, and Diamond Blackfan Anemia. Dr. Veltra has co-authored impactful publications in leading journals such as the European Journal of Paediatric Neurology, Gynecological Endocrinology, and American Journal of Medical Genetics. Her collaborative work has enhanced genotype–phenotype correlations and advanced precision medicine approaches in pediatric and hereditary diseases. With 237 citations, an h-index of 7, and an i10-index of 5, she has established herself as a promising scientist in medical genetics, contributing both to clinical application and academic advancement in human genomics and molecular diagnostics.

Profile: Google Scholar

Featured Publications

Marinakis, N. M., Svingou, M., Veltra, D., Kekou, K., Sofocleous, C., Tilemis, F. N., … (2021). Phenotype‐driven variant filtration strategy in exome sequencing toward a high diagnostic yield and identification of 85 novel variants in 400 patients with rare Mendelian disorders. American Journal of Medical Genetics Part A, 185(8), 2561–2571.

Zouvelou, V., Yubero, D., Apostolakopoulou, L., Kokkinou, E., Bilanakis, M., … Veltra, D. (2019). The genetic etiology in cerebral palsy mimics: The results from a Greek tertiary care center. European Journal of Paediatric Neurology, 23(3), 427–437.

Tilemis, F. N., Marinakis, N. M., Veltra, D., Svingou, M., Kekou, K., Mitrakos, A., … (2023). Germline CNV detection through whole-exome sequencing (WES) data analysis enhances resolution of rare genetic diseases. Genes, 14(7), 1490.

Pavinato, L., Delle Vedove, A., Carli, D., Ferrero, M., Carestiato, S., Howe, J. L., … (2023). CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD. Brain, 146(2), 534–548.

Saffari, A., Lau, T., Tajsharghi, H., Karimiani, E. G., Kariminejad, A., Efthymiou, S., … (2023). The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders. Brain, 146(8), 3273–3288.

Layo-Carris, D. E., Lubin, E. E., Sangree, A. K., Clark, K. J., Durham, E. L., … (2024). Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals. European Journal of Human Genetics, 32(8), 928–937.

Veltra, D., Kosma, K., Papavasiliou, A., Tilemis, F. N., Traeger‐Synodinos, J., … (2022). A novel pathogenic ATP6V1B2 variant: Widening the genotypic spectrum of the epileptic neurodevelopmental phenotype. American Journal of Medical Genetics Part A, 188(12), 3563–3566.

William Blumentals | Clinical Neuroscience | Excellence in Research Award

Published on by Neuroscientists

Dr. William Blumentals | Clinical Neuroscience | Excellence in Research Award

Dr. William Blumentals | Sanofi | United States

Dr. William A. Blumentals is an accomplished epidemiologist and pharmaceutical executive recognized for his leadership in pharmacoepidemiology, real-world evidence generation, and global health outcomes research. He serves as Associate Vice President and Head of Specialty Care Pharmacoepidemiology at Sanofi in Cambridge, Massachusetts, where he oversees a multinational team of epidemiologists across the United States and Europe, driving innovation in inflammation, immunology, oncology, and rare disease research. With a Ph.D. in Epidemiology from the University of South Florida, along with advanced degrees in Statistics, Epidemiology, and Biology, Dr. Blumentals has held senior positions at leading organizations including Shire Pharmaceuticals, Shionogi Inc., and Hoffmann-La Roche. His expertise spans strategic development of large-scale observational studies, organizational leadership, and cross-functional collaboration to optimize evidence-based decision-making in healthcare. As a thought leader in real-world evidence and outcomes research, he has contributed significantly to advancing global epidemiological practices. Dr. Blumentals has authored 36 scientific documents, accumulated 1,594 citations from 1,463 documents, and holds an h-index of 23, reflecting his strong scientific influence and impact in epidemiology and pharmaceutical research.

Profile: Scopus

Featured Publications

Multiple sclerosis and the association with inflammatory bowel disease: Results from a retrospective cohort study. (2025). Multiple Sclerosis and Related Disorders.


Cytokine release syndrome risk model with T-cell engaging therapies. (2025). Cytotherapy.


Evaluating the accuracy of responses by large language models for information on disease epidemiology. (2025). Pharmacoepidemiology and Drug Safety.